Dominique Van Beckhoven
Overview
Explore the profile of Dominique Van Beckhoven including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
543
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reyes-Uruena J, Stoppa G, Pizzolato F, van der Werf M, Deogan C, Cabral-Verissimo V, et al.
Euro Surveill
. 2024 Nov;
29(48).
PMID: 39611209
We analysed trends in new HIV diagnoses and factors contributing to late diagnosis among migrants in countries in the European Union (EU)/European Economic Area (EEA) from 2014 to 2023. Of...
2.
Ilboudo D, Ngwasiri C, Savoye I, Sommet A, Van Beckhoven D, Yombi J, et al.
AIDS Res Ther
. 2024 Jul;
21(1):48.
PMID: 39068430
The Objective of this study was to examine change over time of prevalence of chronic diseases medications (CDM) prescriptions among People living with HIV (PLWH) in Belgium, using Pharmanet database...
3.
De Vos E, Van Gestel L, Brosius I, Kenyon C, Vuylsteke B, De Baetselier I, et al.
Int J Infect Dis
. 2024 Jun;
146:107132.
PMID: 38942168
Objectives: The 2022 mpox epidemic reached a peak in Belgium and the rest of Europe in July 2022, after which it unexpectedly subsided. This study investigates epidemiological, behavioral, and immunological...
4.
Thomadakis C, Gountas I, Duffell E, Gountas K, Bluemel B, Seyler T, et al.
Lancet Reg Health Eur
. 2024 Jan;
36:100792.
PMID: 38188273
Background: Epidemiological data are crucial to monitoring progress towards the 2030 Hepatitis C Virus (HCV) elimination targets. Our aim was to estimate the prevalence of chronic HCV infection (cHCV) in...
5.
Van Praet J, Serrien B, Ausselet N, Darcis G, Demeester R, De Munter P, et al.
J Acquir Immune Defic Syndr
. 2023 Feb;
93(2):e4-e5.
PMID: 36787727
No abstract available.
6.
Van Beckhoven D, Serrien B, Montourcy M, Verhofstede C, Van den Bossche D, Libois A, et al.
BMC Infect Dis
. 2022 Dec;
22(1):901.
PMID: 36463126
Background: To gain insight into the impact of the COVID-19 pandemic and containment measures on the HIV epidemic and services, this study aims to describe HIV trends in 2020 and...
7.
Croxford S, Stengaard A, Brannstrom J, Combs L, Dedes N, Girardi E, et al.
HIV Med
. 2022 Nov;
23(11):1202-1208.
PMID: 36347523
Introduction: In recent years, HIV testing frequency has increased, resulting in more people being diagnosed during seroconversion with a temporarily low CD4 count. Using the current consensus definition of late...
8.
Taccone F, Van Goethem N, De Pauw R, Wittebole X, Blot K, Van Oyen H, et al.
Lancet Reg Health Eur
. 2022 Feb;
2:100019.
PMID: 35104305
Background: Several studies have investigated the predictors of in-hospital mortality for COVID-19 patients who need to be admitted to the Intensive Care Unit (ICU). However, no data on the role...
9.
Penalvo J, Genbrugge E, Mertens E, Sagastume D, van der Sande M, Widdowson M, et al.
BMJ Open
. 2021 Sep;
11(9):e053393.
PMID: 34531225
Objectives: The widespread use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) by patients with chronic conditions raised early concerns on the potential exacerbation of COVID-19 severity and...
10.
Fischer N, Peeters I, Klamer S, Montourcy M, Cuylaerts V, Van Beckhoven D, et al.
BMC Infect Dis
. 2021 Sep;
21(1):947.
PMID: 34521367
Background: Chlamydia trachomatis (chlamydia) is the most diagnosed sexually transmitted infection in Belgium. Screening programs focus on young women, due to the implications of chronic asymptomatic infections for reproductive health....